Meckler Jeffrey A

Number of records: 33
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
19-May-23 4:05 PM
View: 
Travere Therapeutics, Inc. (TVTX) 17-May-23Grant 4,500----6%
70.0K to 74.5K
22-Nov-22 8:00 AM
View: 
Indaptus Therapeutics, Inc. (INDP) 21-Nov-22Purchase 9,600$1.90$18,240.0015%
65.77K to 75.37K
22-Nov-22 8:00 AM
View: 
Indaptus Therapeutics, Inc. (INDP) 18-Nov-22Private Purchase 400$1.76$705.48< 1%
65.37K to 65.77K
12-Sep-22 9:00 AM
View: 
Indaptus Therapeutics, Inc. (INDP) 08-Sep-22Private Purchase 10,308$2.80$28,862.4019%
55.07K to 65.37K
08-Sep-22 9:00 AM
View: 
Indaptus Therapeutics, Inc. (INDP) 07-Sep-22Purchase 8,632$2.57$22,184.2019%
46.43K to 55.07K
08-Sep-22 9:00 AM
View: 
Indaptus Therapeutics, Inc. (INDP) 06-Sep-22Private Purchase 1,060$2.44$2,586.402%
45.37K to 46.43K
07-Jun-22 8:00 AM
View: 
Indaptus Therapeutics, Inc. (INDP) 06-Jun-22Private Purchase 19,727$2.63$51,882.0077%
25.65K to 45.37K
12-May-22 8:26 PM
View: 
Travere Therapeutics, Inc. (TVTX) 11-May-22Grant 3,000----4%
67.0K to 70.0K
19-Nov-21 9:16 AM
View: 
Indaptus Therapeutics, Inc. (INDP) 18-Nov-21Market Purchase 11,187$5.82$65,108.3077%
14.46K to 25.65K
16-Sep-21 6:22 PM
View: 
Indaptus Therapeutics, Inc. (INDP) 14-Sep-21Market Purchase 12,000$7.00$84,000.00488%
2.46K to 14.46K
54%
18-May-21 9:19 PM
View: 
Travere Therapeutics, Inc. (TVTX) 14-May-21Grant 3,000----5%
64.0K to 67.0K
19-May-20 8:00 PM
View: 
Travere Therapeutics, Inc. (TVTX) 15-May-20Grant 3,000----5%
61.0K to 64.0K
29-Aug-19 4:16 PM
View: 
Intec Pharma Ltd. (NTEC) 28-Aug-19Market Purchase 20,000$0.68$13,620.0011%
176.76K to 196.76K
(80%)
27-Aug-19 4:18 PM
View: 
Intec Pharma Ltd. (NTEC) 23-Aug-19Market Purchase 100,000$0.46$45,700.00130%
76.76K to 176.76K
(70%)
10-May-19 8:37 PM
View: 
Travere Therapeutics, Inc. (TVTX) 08-May-19Grant 2,000----3%
59.0K to 61.0K
11-May-18 9:06 PM
View: 
Travere Therapeutics, Inc. (TVTX) 09-May-18Grant 2,500----4%
56.5K to 59.0K
18-May-17 6:19 PM
View: 
Travere Therapeutics, Inc. (TVTX) 17-May-17Grant 2,500----5%
54.0K to 56.5K
19-May-16 1:30 PM
View: 
Travere Therapeutics, Inc. (TVTX) 18-May-16Grant 2,000----4%
52.0K to 54.0K
17-Mar-16 4:05 PM
View: 
Cocrystal Pharma, Inc. (COCP) 15-Mar-16Private Purchase 294,118$0.51$150,000.0081%
363.04K to 657.16K
07-Mar-16 8:50 PM
View: 
Travere Therapeutics, Inc. (TVTX) 04-Mar-16Market Purchase 5,000$15.31$76,564.5011%
47.0K to 52.0K
(3%)
03-Mar-16 6:49 PM
View: 
Travere Therapeutics, Inc. (TVTX) 03-Mar-16Market Purchase 10,000$14.45$144,500.0027%
37.0K to 47.0K
7%
28-Dec-15 4:05 PM
View: 
Cocrystal Pharma, Inc. (COCP) 23-Dec-15Market Purchase 100,000$0.58$57,870.0038%
263.04K to 363.04K
(91%)
01-Jul-15 4:03 PM
View: 
QLT Inc. (NVLNF) 29-Jun-15Option Exercise 25,000$3.48$87,125.0030%
82.0K to 107.0K
10-Jun-15 2:02 PM
View: 
Travere Therapeutics, Inc. (TVTX) 08-Jun-15Grant 2,000----6%
35.0K to 37.0K
09-Jun-15 9:00 PM
View: 
QLT Inc. (NVLNF) 07-Jun-15Option Exercise 10,000----14%
72.0K to 82.0K
27-Mar-15 4:16 PM
View: 
Cocrystal Pharma, Inc. (COCP) 25-Mar-15Purchase 163,043$0.92$150,000.00163%
100.0K to 263.04K
19-Dec-14 2:13 PM
View: 
QLT Inc. (NVLNF) 18-Dec-14Market Purchase 20,000$3.60$72,000.0038%
52.0K to 72.0K
(49%)
17-Dec-14 3:10 PM
View: 
QLT Inc. (NVLNF) 15-Dec-14Option Exercise 2,000----4%
50.0K to 52.0K
15-Dec-14 4:17 PM
View: 
Cocrystal Pharma, Inc. (COCP) 11-Dec-14Purchase 100,000$0.46$45,610.00100%
0 to 100.0K
25-Nov-14 3:16 PM
View: 
Travere Therapeutics, Inc. (TVTX) 25-Nov-14Market Purchase 15,000$8.60$129,050.0075%
20.0K to 35.0K
< 1%
10-Oct-14 4:55 PM
View: 
Travere Therapeutics, Inc. (TVTX) 08-Oct-14Grant 20,000----100%
0 to 20.0K
01-Jul-13 2:29 PM
View: 
QLT Inc. (NVLNF) 28-Jun-13Market Purchase 30,000$4.36$130,800.00150%
20.0K to 50.0K
(58%)
06-May-13 3:41 PM
View: 
QLT Inc. (NVLNF) 03-May-13Market Purchase 20,000$7.96$159,200.00100%
0 to 20.0K
(56%)